COVID-19 has left a trail of uncertainty in its wake as the burden weighing on pharmaceutical companies working to get their clinical trials back on track appears somewhat insurmountable. These challenges facing the pharmaceutical industry are multifaceted as the...
While the speedy development of a COVID-19 vaccine lends itself to a faster “return to normal”, the expedience raises some very legitimate concerns about the quality of such a rushed product. Due to the immense pressure to approve a vaccine quickly, a subpar and...